Aciduricity is a major cariogenic characteristic of Streptococcus mutans, and various genes have been implicated in this ability of S. mutans. Sixteen S. mutans mutant strains, each defective in a different gene, were constructed and their aciduricity was assessed. Of the mutants, the diacylglycerol kinase (Dgk) homologue mutant and the glucose-1-phosphate uridylyltransferase mutant strains displayed distinctly attenuated aciduricity when grown at pH 5.5. Considering the delayed growth rate of the latter at neutral pH, the dgk homologue appeared to be a gene responding specifically to pH reduction among the 16 genes tested. Two known eukaryotic Dgk inhibitors, R59949 and R59022, were selected as candidate inhibitors of the S. mutans Dgk homologue. R59949, but not R59022, significantly reduced the growth of S. mutans at pH ,5.4. R59949 did not affect either the final pH of the medium or the internal pH of the organism. Furthermore, R59949 inhibited about 20 % of Dgk kinase activity. Novel derivatives of R59949 may be useful for preventing the development of dental caries caused by S. mutans.
INTRODUCTION
Streptococcus mutans, the major aetiological factor in human dental caries, is capable of forming the biofilm commonly known as 'dental plaque' on the surfaces of teeth (Loesche, 1986; Tanzer et al., 2001) . Within the dental plaque, S. mutans synthesizes large amounts of acids from fermentable dietary carbohydrates. Acid accumulation can eventually cause the teeth's hard, crystalline structure to be dissolved, resulting in the formation of carious lesions (Quivey et al., 2001) . S. mutans has the ability to tolerate the typically low pH of dental plaque and continue to produce acids, contributing to its cariogenicity. The tolerance of low pH is considered to be one of this micro-organism's most important virulence factors.
Diacylglycerol kinase (Dgk) is an enzyme that phosphorylates diacylglycerol (DG) to produce phosphatidic acid. In eukaryotic cells, both DG and phosphatidic acid are important lipid second messengers that regulate the expression of a number of enzymes. Therefore, Dgk plays an important role in regulating many intracellular signalling pathways (Kanoh et al., 2002; Mérida et al., 2008; Topham & Prescott, 1999; Van Blitterswijk & Houssa, 2000) . In bacteria, Dgk functions in the recycling of DG produced during the turnover of membrane phospholipids (Hasin & Kennedy, 1982; Rotering & Raetz, 1983) , and similar to eukaryotic Dgk, it also plays an important role in microbial physiology under conditions of environmental stress (Raetz & Newman, 1979; Walsh et al., 1986; Yamashita et al., 1993) .
Many researchers have sought to explain the mechanisms of acid tolerance in S. mutans, and various genes contributing to this property have been identified. In a previous study , we reported that the C-terminal tail of a Dgk homologue was indispensable for tolerance to acid stress in S. mutans and that the Dgk homologue's kinase activity was closely related to the acid tolerance of this organism. Furthermore, a dgk deletion mutant isolate exhibited markedly reduced levels of smooth-surface carious lesions in pathogen-free rats . Inhibitors of the Dgk homologue's enzymic activity may therefore be useful in attenuating the virulence of S. mutans.
In this study, we generated mutations in genes that have been previously reported to be involved in acid tolerance in IP: 54.70.40.11
On: Sat, 27 Apr 2019 17:27:57 S. mutans and examined their contribution to acid tolerance, in order to determine the most desirable target for anti-caries agents. Additionally, we investigated the effects of inhibitors of the putative candidate on the acid tolerance of S. mutans, to assess their potential usefulness as anti-caries agents.
METHODS
Bacterial strains and culture conditions. Escherichia coli strain RZDGK11 producing full-size S. mutans Dgk protein was constructed through transformation of the mutant strain RZ6, which lacks a functional E. coli dgk gene, as described previously ). E. coli strains and S. mutans strains were maintained and grown routinely as described previously (Shibata et al., 2002) . Antibiotics were used at the following concentrations: 200 mg erythromycin ml -1 or 50 mg ampicillin ml -1 for E. coli; 10 mg erythromycin ml -1 for S. mutans.
DNA manipulation. Standard DNA recombinant procedures, such as DNA isolation, endonuclease restriction, ligation and agarose gel electrophoresis were carried out as described by Sambrook & Russell (2001) . Transformation of S. mutans and E. coli was performed as described elsewhere (Hanahan, 1983; Perry et al., 1983) .
Construction of the mutant forms of the genes that contribute to aciduricity in S. mutans. In this study, we created S. mutans UA159 mutant strains carrying mutated forms of the following 15 genes: aguB (Griswold et al., 2004) , brpA , ciaH (Ahn et al., 2006) , clpP (Lemos & Burne, 2002) , dltC (Boyd et al., 2000) , ffh (Kremer et al., 2001) , ftsY (Hasona et al., 2005) , glrA (Cvitkovitch et al., 2000) , gluA (Yamashita et al., 1998) , htrA (Biswas & Biswas, 2005) , lgl (Korithoski et al., 2007) , luxS (Wen & Burne, 2004) , ropA (Wen et al., 2005) , uvrA (Hanna et al., 2001) and yidC2 (Dong et al., 2008) . The dltC and ciaH genes were replaced by an erythromycin resistance gene using double cross-over homologous recombination, as described previously ). The other mutants were generated through the interruption of linear target gene fragments by the same erythromycin resistance gene, inserted at appropriate restriction sites, using double cross-over homologous recombination. Correct insertions or replacements in transformants were confirmed by PCR. The mutant UADGK1 , in which the C-terminal 10 amino acid residues of Dgk were deleted, was used as a dgk mutant. The primers used to generate and confirm the identities of the mutants are listed in Supplementary Table S1 (available with the online journal).
Evaluation of the acid sensitivity of the strains. The 16 mutant strains and the wild-type control UA159 strain cells were grown in brain heart infusion broth (BHI; Difco) overnight at 37 uC in 5 % CO 2 . The cultures were then diluted 1 : 10 into fresh BHI and grown to an OD 550 of~0.5. Aliquots (20 ml) of the cell suspensions having the same turbidity were inoculated into wells that contained 200 ml fresh BHI medium adjusted to either pH 7.4 or 5.5 with 50 mM sodium acetate buffer. Growth was monitored by measuring the optical density at 550 nm using a Spectramax 340PC 384 microplate spectrophotometer (Molecular Devices). Wells containing only BHI were used as controls. Growth curves were generated from the data obtained from three independent experiments. In addition, each strain was grown at pH 7.4 or 5.5, as described above, and incubated for one additional hour after reaching the maximum OD 550 . The cultures were then serially diluted, plated on BHI agar plates, and incubated at 37 uC in 5 % CO 2 for 2 days before colonies were counted. The mutant/wild-type c.f.u. ratio was calculated. Three independent experiments were performed in triplicate.
Growth inhibition assay. The Dgk inhibitors, 6-{2-{4-[(p-fluorophenyl)phenylmethylene]-1-piperidinyl}ethyl}-7-methyl-5H-thiazolo(3,2-a)pyrimidine-5-one (R59022) and 3-{2-{4[bis-(4fluorophenyl)methylene]-1-piperidinyl}ethyl}-2,3-dihydro-2-thioxo-4(1H) quinazolinone (R59949) were purchased from Merck. To examine the effects of R59022 and R59949 on the growth of S. mutans, wild-type UA159 cells were inoculated into microtitre plate wells, each containing 200 ml fresh BHI medium (pH 7.4, 5.5, 5.4, 5.3, 5.2, 5 .1 or 5.0) containing R59022 (100 mM), R59949 (25 mM) or DMSO (control). After incubation at 37 uC in 5 % CO 2 for 16 h the OD 550 was measured. Three independent experiments were performed in triplicate.
Measurement of intracellular pH. Intracellular pH measurements were performed as described by Sawatari & Yokota (2007) . Briefly, cells were cultured until mid-exponential phase, harvested and washed twice with buffer A [150 mM potassium phosphate (pH 6.5), 1 mM MgSO 4 ]. The cells were resuspended to an OD 550 value of 0.5 in buffer A and incubated at 37 uC for 30 min in the presence of carboxyfluorescein diacetate succinimidyl ester (cFDA SE; Molecular Probes), a fluorescent pH probe. To eliminate unbound probe, the cells were incubated with glucose for 1 h and then washed once in buffer A. The cells were subsequently resuspended in buffer B (buffer A supplemented with 100 mM 2-morpholinoethanesulfonic acid), and the intracellular pH was measured. Three independent experiments were performed.
Kinase assay. A kinase assay was conducted as described previously . Kinase activity in cell lysates was examined by an octylglucoside mixed-micelle assay (Preiss et al., 1986) , using undecaprenol (Larodan Fine Chemicals) as a substrate. The synthesized undecaprenylphosphate, radiolabelled by [c-32 P]ATP, was separated on silica gel 60 TLC plates (Merck), detected by BAS2500 (Fujix), and finally represented as photostimulated luminescence (PSL). For the kinase inhibition assay, the Dgk inhibitors were used at a concentration of 100 mM. Three independent experiments were performed.
RESULTS AND DISCUSSION

Mutant strain acid sensitivity
To examine the effects of the mutations on S. mutans acid tolerance, the 16 mutant strains and the wild-type control UA159 strain cells were grown in BHI broth adjusted to pH 7.4 or 5.5 (Fig. 1, Table 1 ). At pH 7.4, the brpA, ciaH, dgk, dltC, htrA, lgl, luxS, ropA and uvrA mutant cells grew similarly to the wild-type UA159 cells, whereas the other mutant strains, particularly the gluA and yidC2 mutant strains, grew more slowly than the wild-type strain (Fig.  1a ). Inactivation of aguB, brpA, glrA, htrA, lgl, luxS, ropA, or uvrA did not significantly affect the acid tolerance of S. mutans, as assessed by growth at pH 5.5 (Fig. 1b) . In contrast, the ciaH, clpP, dgk, dltC, ffh, ftsY, gluA and yidC2 mutant strains displayed significantly reduced growth rates. Notably, the dgk and the gluA mutant strains grew extremely slowly at pH 5.5. Not all mutant strains grew at rates similar to that of wild-type UA159 cells, even at pH 7.4. Calculation of the mutant/wild-type strain c.f.u. ratio at pH 5.5 revealed that the inactivation of the dgk or gluA gene markedly attenuated the aciduricity of S. mutans (Table 1 ). The growth data of all strains tested are IP: 54.70.40.11
On: Sat, 27 Apr 2019 17:27:57 Fig. 1 . Growth curves of S. mutans UA159 (wild-type) and mutant strains grown in BHI medium at pH 7.4 (a) or 5.5 (b). Growth was defined in terms of increased OD 550 and was calculated by subtracting the initial OD 550 value from those values recorded after the indicated periods of growth. Data represent the means of three independent experiments. Table 1 . Growth data of S. mutans UA159 and 16 mutant strains at pH 7.4 and 5.5
Doubling time was calculated based on the formula ln Z2ln Z 0 5k (t2t 0 ), where k is the growth rate, and g50.693/k, where g is the doubling time. Table 1 . The gluA mutant strain exhibited a reduced growth rate at both neutral and acidic pH, and thus we focused on dgk as a gene responding specifically to pH reduction in S. mutans.
Effects of Dgk inhibitors on the growth of S. mutans
Mammalian Dgks have been extensively studied, and several compounds that inhibit their activity have been identified. R59022 and R59949 are the most commonly used inhibitors, and both interact directly with Dgk. R59022 inhibits Dgk without affecting phosphodiesterase or phosphatidylinositol kinase (De Chaffoy de Courcelles et al., 1985) . R59949 acts on the enzyme's catalytic domain (Jiang et al., 2000) . In contrast, the inhibition of prokaryotic Dgk enzymes has not been studied. We therefore evaluated the effects of R59022 and R59949 on the growth of S. mutans. Both inhibitors can normally be used at a concentration of 100 mM in the hydrophobic conditions of enzyme assays. However, in the growth assay, R59949 did not fully dissolve in BHI medium (hydrophilic) at a concentration of 100 mM, although R59022 did. Thus, R59022 and R59949 were used at concentrations of 100 and 25 mM, respectively, in the growth inhibition assay. We confirmed that the addition of the inhibitors did not affect the pH of the buffered BHI medium. While neither R59022 nor R59949 influenced the growth of S. mutans at pH 7.4, R59949 significantly inhibited the growth of S. mutans at acidic pH ( Fig. 2a) . R59022 had no effect on S. mutans growth rate (Fig. 2b) . The inhibition ratio of R59949 increased with decreasing pH, with ratios of 13, 29, 58, 68 and 78 % at pH 5.4, 5.3, 5.2, 5.1 and 5.0, respectively.
Effect of the Dgk inhibitors on the enzymic activity of S. mutans Dgk
The effects of R59022 and R59949 on the kinase activity of S. mutans Dgk were assayed. Cell lysates obtained from E. coli RZDGK11 expressing full-length S. mutans Dgk protein were used as crude S. mutans Dgk samples in a kinase activity assay. It has been shown that cell lysates from E. coli RZ6, the parent strain of RZDGK11, do not exhibit any kinase activity when provided with undecaprenol as a substrate . We first confirmed that the addition of the inhibitors did not affect the pH of the reaction mixture for kinase activity assay. Neither R59022 nor R59949 affected Dgk kinase activity at pH 7.4 (data not shown), consistent with the above observations that the inhibitors did not affect the growth rate of S. mutans at neutral pH.
As intracellular pH is not necessarily equal to that of the local environment, we determined the intracellular pH of S. mutans at various external pH values. The intracellular pH values of S. mutans were 6.57±0.07, 6.51±0.07, 6.45± 0.07, 6.38±0.07, 6.32±0.07 and 6.26±0.07 at external pH values of 5. 5, 5.4, 5.3, 5.2, 5.1 and 5.0, respectively. Moreover, the addition of R59949 did not affect the intracellular pH. Considering that R59949 showed greater than 50 % inhibition of S. mutans growth at pH 5.2, the kinase inhibition experiment was performed at pH 6.4. The kinase activities in E. coli RZDGK11 cell lysates using undecaprenol as a substrate were 37.3±2.9 PSL mm 22 and 29.4±4.3 PSL mm 22 , respectively, in the absence and presence of R59949, reflecting an inhibition of about 20 % (P,0.05, Student's t-test) by R59949. In contrast, R59022 did not inhibit kinase activity under these conditions (data not shown). Collectively, these results support the previous conclusion that Dgk kinase activity is closely related to S. mutans acid tolerance. However, the inhibitory effect of R59949 on Dgk kinase activity was not as strong as expected. In our previous study , S. mutans UADGK6 expressing Dgk6, a truncated form of Dgk lacking 5 Cterminal amino acids, exhibited 40 and 60 % reduced growth at pH 5.5 and 5.4, respectively, compared with S. mutans expressing full-length Dgk. However, R59949 had no effect on the growth of S. mutans at pH 5.5 and caused significant growth inhibition (.50 %) at pH 5.2. This indicates that the effect of R59949 was weaker than that of the C-terminal truncation of Dgk. Thus, given that Dgk6 displayed 60 % reduced kinase activity with undecaprenol as a substrate, compared with full-length Dgk, the calculated 20 % reduction in Dgk kinase activity caused by R59949 seems reasonable.
Unlike eukaryotic Dgks, bacterial Dgks, including that of S. mutans, are small proteins exhibiting minimal amino acid sequence similarity with their eukaryotic homologues. Moreover, the principal substrate for S. mutans Dgk is undecaprenol, not DG (Lis & Kuramitsu, 2003) . Nevertheless, R59949, an inhibitor of mammalian Dgks, inhibited the Dgk activity and acid tolerance of S. mutans. A second inhibitor of mammalian Dgks, R59022, produced no such effect. Both R59022 and R59949 are known to selectively inhibit type I Dgks (De Chaffoy de Courcelles et al., 1985; Jiang et al., 2000) , although their inhibitory effects on different Dgk isoforms have not been comprehensively evaluated. Thus, a few (minor) differences in isoform selectivity between R59949 and R59022 may exist. Moreover, differences in the molecular structures of R59949 and R59022 may contribute to the difference in their effectiveness against prokaryotic Dgks. It is not clear why an inhibitor of mammalian Dgks also inhibited Dgk activity in S. mutans. However, our study clearly shows that the addition of R59949 caused a reduction in aciduricity, one of the main virulence factors of S. mutans. Unfortunately, the direct use of R59949 in patients is not realistic. The development of more potent Dgk inhibitors specific for prokaryotic enzymes, through specific modifications based on comparisons of the molecular structures of R59949 and R59022, may lead to the discovery of new anti-caries agents.
